Clinical Trial Update: Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the effectiveness and toxicity of adjuvant ultra-hypofractionated radiotherapy in female breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Prevent Senior Institute | Conditions: Breast Cancer Female | Phase 2 | Status: COMPLETED